Search

You searched for "prostate"

508 results found

Prostate Cancer UK: PSA Consensus Conference 2024

20 September 2024
During the conference, you'll get up-to-date information on the latest consensus regarding the PSA blood test. You'll also be able to discuss the diagnostic process for secondary care and learn how to proactively manage conversations about prostate health with patients who are at higher risk. You’ll have plenty of opportunities to ask questions, interact with peers, and apply what you learn through engaging case studies. 9am – 12.30pm

Aqua Medical: LATP Prostate Biopsy with Perino-Flex

17 January 2025
Join renowned urologist Mr Ahmed Ali & Colleagues for an intensive hands-on LATP (Local Anesthesia Transperineal) Training Course featuring the groundbreaking Pernio-Flex, the world’s first prostate biopsy guide with angulation. Designed for urology professionals eager to enhance biopsy precision and patient comfort, this course covers every aspect of LATP technique using Pernio-Flex’s innovative design, which enables precise angulation for improved accuracy and accessibility

Royal College of Physicians and Surgeons of Glasgow: Prostate Cancer Training and Update Day

28 February 2025
The Prostate Cancer Training and Update Day will provide cancer specialists and associates healthcare professionals a chance to hear from national and international experts on the latest prostate cancer diagnosis and management. This in-person only programme will be of interest to consultants, trainees of all grades, SAS clinicians and specialist nurses in urology, oncology, radiology and pathology.

Simple spit test could finally turn the tide on prostate cancer

10 April 2025
Saliva test which analyses genetic variants in DNA is better than the PSA blood test at assessing prostate cancer risk for some men, and doesn’t require a visit to the GP. The test gave fewer false positive results and picked...

Prostate cancer: Black men more likely to be diagnosed at later stages

9 January 2025 | Charities, Research & Development
Latest data shows Black men have higher rates of stage 3 or stage 4 prostate cancer diagnoses compared with white men. Black men diagnosed at a later stage in their 60s are 14% less likely to get NICE approved treatment...

BXTAccelyon becomes global distribution partner for new online prostate MRI self-learning tool to enhance prostate cancer diagnosis

6 May 2020 | Contracts & Distributors
BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, and distribution partner for PrecisionPoint™, the...

PROSPACKS supports prostate cancer patients starting treatment in Scotland

22 April 2025
Men across Scotland undergoing treatment for prostate cancer can benefit from new care and support packs thanks to a project by charity Prostate Scotland and long-term funder, the Grand Lodge of Scotland. PROSPACKS – tailored packs for men beginning radiotherapy,...

Prostate Scotland Robotic Training, Fellowship, Clinical Visit & Research Awards

17 September 2024 | Research & Development, Awards, Conferences & Anniversaries, Charities
Prostate Scotland, in association with The Urology Foundation, has a number of awards available to support the training of urologists, surgery nurses and first surgical assistants in Scotland in robotic assisted prostate cancer surgery. The awards – ranging in value...

Fusion Bx 2.0 targeted prostate biopsy solution receives CE Mark

4 November 2019 | Research & Development
Focal Healthcare, an innovator of image-guided prostate cancer technology, has received CE Mark for its Fusion BxTM 2.0 prostate fusion biopsy solution.

APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

27 February 2025 -28 February 2025
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth.

EAU (European Association of Urology) Masterclass on Focal therapy for localised prostate cancer

5 December 2024 -6 December 2024
Focal Therapy (FT) is a promising treatment option aimed at improving the management of localised prostate cancer. This masterclass will provide you with an extensive review of the rationale for FT, the patient selection modalities and the available energy sources (HIFU, Cryo, IRE, Laser, Brachytherapy). Gain further knowledge and better understand the FT benefits.

Prostate Cancer UK: Specialist Education Conference 2025 (Free)

26 March 2025 -27 March 2025
You’ll hear from a panel of expert speakers who’ll share their knowledge and best practice guidance about prostate cancer care. They’ll provide the latest information and guidance, helping you to provide best practice care for your patients. You’ll also cover CPD requirements by attending. From 9am - 12 noon.